Utilizing the Hofmeister Effect to Induce Hydrogelation of Nonionic Supramolecular Polymers into a Therapeutic Depot

Nonionic hydrogels are of particular interest for long-term therapeutic implantation due to their minimal immunogenicity relative to their charged counterparts. However, in situ formation of nonionic supramolecular hydrogels under physiological conditions has been a challenging task. In this context, we report on our discovery of salt-triggered hydrogelation of nonionic supramolecular polymers (SPs) formed by self-assembling prodrug hydrogelators (SAPHs) through the Hofmeister effect. The designed SAPHs consist of two SN-38 units, which is an active metabolite of the anticancer drug irinotecan, and a short peptide grafted with two or four oligoethylene glycol (OEG) segments. Upon self-assembly in water, the resultant nonionic SPs can be triggered to gel upon addition of phosphate salts. Our 1H NMR studies revealed that the added phosphates led to a change in the chemical shift of the methylene protons, suggestive of a disruption of the water-ether hydrogen bonds and consequent reorganization of the hydration shell surrounding the SPs. This deshielding effect, commensurate with the amount of salt added, likely promoted associative interactions among the SAPH filaments to percolate into a 3D network. The formed hydrogels exhibited a sustained release profile of SN-38 hydrogelator that acted potently against cancer cells. Non-ionic supramolecular polymers, formed by self-assembly of drug-peptide conjugates, can be induced to undergo a sol-gel transition using the Hofmeister Effect, in which the well-hydrated anions disrupt the hydration shell around the supramolecular polymers by polarizing the water molecules closely bound to their surfaces.image

Automated summary

Non-ionic hydrogels are of interest for long-term therapeutic implantation due to their low immunogenicity. This study reports the formation of non-ionic supramolecular polymer hydrogels triggered by salt. The hydrogels exhibit sustained release of an anticancer drug and potent activity against cancer cells.